FDA Inspection
Texas Center for Reproductive HealthTexas Center for Reproductive Health – FDA Inspection, Feb 12, 2013
Record Details
This FDA Inspection record concerns Texas Center for Reproductive Health, with an inspection on February 12, 2013, issued by the Center for Biologics Evaluation and Research, covering biologics.
- Inspection Date
- February 12, 2013
- Product Type
- Biologics
View Company Profile
ID · aed49ed4-825a-4d18-bcc7-d76292b0603a
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 818101
- FDA center
- Biologics
- Project area
- Human Cellular, Tissue, and Gene Therapies
FDA Citations
1- 21 CFR 1271.75(a)(1)Risk factors, clinical evidence
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Texas Center for Reproductive Health
4| Date | Classification | Office | Project area |
|---|---|---|---|
| March 6, 2025 | Not classified | Dallas District Office | |
| November 7, 2018 | NAI | Center for Biologics Evaluation and Research | Human Cellular, Tissue, and Gene Therapies |
| February 4, 2016 | VAI | Center for Biologics Evaluation and Research | Human Cellular, Tissue, and Gene Therapies |
| May 20, 2010 | NAI | Center for Biologics Evaluation and Research | Human Cellular, Tissue, and Gene Therapies |
Other documents for Texas Center for Reproductive Health
- FDA Inspection 1263527 - 2025-03-06
- FDA Inspection 1073733 - 2018-11-07
- FDA Inspection 957609 - 2016-02-04
- FDA Inspection 665565 - 2010-05-20
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.